Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT07313592
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 30 Years
- Healthy Volunteers
- Not accepted
Interventions
- ChromoSeq® assay testing — DEVICEBone marrow and/or peripheral blood sample will be collected and ChromoSeq® assay testing will be completed.
Study Details
This is a prospective specimen collection study evaluating the feasibility of using the ChromoSeq® assay for upfront classification in a real-time clinical setting of pediatric and young adult acute lymphoid leukemia (ALL) patients. Sixty patients will undergo collections of bone marrow and/or peripheral blood for the ChromoSeq® assay at time of initial workup, and the patients will then be followed for clinical outcomes for up to 65 months.
Key Dates
- Start date
- Jun 3, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 15, 2028
- Completion
- Jul 15, 2028
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: Child and Young Adult acute lymphoid leukemia (ALL) patientsAt time of initial workup, patients will undergo bone marrow and/or peripheral blood collection for ChromoSeq® (requires 1 mL of peripheral blood or bone marrow aspirate).
Primary Outcome Measure
Rate of success of ChromoSeq® [ Time Frame: Time of specimen collection to completion of results (total estimated time is 15 days) ]
Central Contacts
- Margaret Ferris, MD, PhD314-454-6018
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Washington University School of Medicine/St. Louis Children's Hospital | St Louis | Missouri | 63110 | Margaret Ferris, MD, PhD (PRINCIPAL_INVESTIGATOR) Feng Gao, PhD (SUB_INVESTIGATOR) |
Find similar trials in St Louis, MO
By condition
By specialty
Related Studies
- A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 MutationPHASE1/PHASE2 · Recruiting · Syndax Pharmaceuticals · Duarte, California
- The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyPHASE1/PHASE2 · Recruiting · PedAL BCU, LLC · Birmingham, Alabama
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruiting · Alliance for Clinical Trials in Oncology · Anchorage, Alaska
- Biology Studies of Hematologic CancersEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland